Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, study at a single clinical site investigating the effect
of methylnaltrexone and naloxone versus placebo in healthy males who have received a
short-acting opioid, remifentanil.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.